Cite
HARVARD Citation
Messous, S. et al. (2022). Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial. Therapeutic advances in respiratory disease. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Messous, S. et al. (2022). Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial. Therapeutic advances in respiratory disease. p. . [Online].